Aisha Masood

2.1k total citations
35 papers, 465 citations indexed

About

Aisha Masood is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Aisha Masood has authored 35 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Aisha Masood's work include CAR-T cell therapy research (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Aisha Masood is often cited by papers focused on CAR-T cell therapy research (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Aisha Masood collaborates with scholars based in United States, Switzerland and Germany. Aisha Masood's co-authors include Sabah Sallah, Asher Chanan‐Khan, Taimur Sher, Priya Patel, Mehul Patel, Aneel Paulus, Kasyapa S. Chitta, Kena C. Miller, Abhisek Swaika and Kelvin H. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Aisha Masood

35 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aisha Masood United States 12 232 205 89 79 76 35 465
Ulf Schnetzke Germany 13 119 0.5× 227 1.1× 69 0.8× 101 1.3× 124 1.6× 38 521
Toshiki Terao Japan 11 115 0.5× 135 0.7× 41 0.5× 17 0.2× 72 0.9× 60 377
Roninson Ib United States 6 599 2.6× 259 1.3× 59 0.7× 52 0.7× 121 1.6× 7 817
Simone Jüliger United Kingdom 11 82 0.4× 353 1.7× 32 0.4× 81 1.0× 152 2.0× 13 617
B W Futscher United States 7 324 1.4× 316 1.5× 43 0.5× 37 0.5× 58 0.8× 7 578
Christopher Parsons United States 11 136 0.6× 166 0.8× 40 0.4× 179 2.3× 63 0.8× 23 466
Katja Conrath Belgium 15 105 0.5× 243 1.2× 111 1.2× 69 0.9× 84 1.1× 23 718
Daniela De Martino Italy 12 137 0.6× 198 1.0× 18 0.2× 87 1.1× 71 0.9× 15 475
Steven Schutt United States 14 100 0.4× 236 1.2× 63 0.7× 45 0.6× 398 5.2× 32 673
Brian Kwok United States 7 56 0.2× 205 1.0× 120 1.3× 172 2.2× 38 0.5× 15 516

Countries citing papers authored by Aisha Masood

Since Specialization
Citations

This map shows the geographic impact of Aisha Masood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha Masood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha Masood more than expected).

Fields of papers citing papers by Aisha Masood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisha Masood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha Masood. The network helps show where Aisha Masood may publish in the future.

Co-authorship network of co-authors of Aisha Masood

This figure shows the co-authorship network connecting the top 25 collaborators of Aisha Masood. A scholar is included among the top collaborators of Aisha Masood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisha Masood. Aisha Masood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landsburg, Daniel J., Matthew J. Frigault, S.R. Foley, et al.. (2025). Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry. Journal for ImmunoTherapy of Cancer. 13(2). e009890–e009890. 3 indexed citations
2.
Degtyarev, Evgeny, Joshua Brody, Aby Buchbinder, et al.. (2024). End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?. Future Oncology. 20(22). 1601–1615. 1 indexed citations
3.
Hao, Yanni, Wei‐Chun Hsu, Craig S. Parzynski, et al.. (2023). Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma. Journal of Comparative Effectiveness Research. 12(7). e220173–e220173. 3 indexed citations
4.
Fowler, Nathan, Michael Dickinson, Monalisa Ghosh, et al.. (2022). Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study. Transplantation and Cellular Therapy. 29(1). 60.e1–60.e4. 12 indexed citations
5.
6.
7.
8.
Masood, Aisha. (2017). THREATS TO SAFETY OF JOURNALISTS IN PAKISTAN – RISK ASSESSMENT BY JOURNALISTS AT HIGH RISK. SHAREOK (University of Oklahoma). 1 indexed citations
9.
Chitta, Kasyapa S., A. Nazmul H. Khan, Abhisek Swaika, et al.. (2013). Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cells. Leukemia & lymphoma. 55(3). 652–661. 20 indexed citations
10.
11.
Chitta, Kasyapa S., Aneel Paulus, Sikander Ailawadhi, et al.. (2012). Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute – Waldenström Macroglobulinemia 1. Leukemia & lymphoma. 54(2). 387–396. 19 indexed citations
12.
Sher, Taimur, Sikander Ailawadhi, Kena C. Miller, et al.. (2011). A steroid‐independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. British Journal of Haematology. 154(1). 104–110. 10 indexed citations
13.
14.
Chanan‐Khan, Asher, Kasyapa S. Chitta, Aneel Paulus, et al.. (2011). Biological effects and clinical significance of lenalidomide‐induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response. British Journal of Haematology. 155(4). 457–467. 58 indexed citations
15.
Masood, Aisha, Kasyapa S. Chitta, Aneel Paulus, et al.. (2011). Downregulation of BCL2 by AT‐101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. British Journal of Haematology. 157(1). 59–66. 24 indexed citations
16.
Masood, Aisha, Taimur Sher, & Asher Chanan‐Khan. (2011). Reply to tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response. Cancer. 118(6). 1739–1739. 1 indexed citations
17.
Masood, Aisha, Kasyapa S. Chitta, Kiersten Marie Miles, et al.. (2010). An Investigational Proteasome Inhibitor MLN9708 (MLN2238) Induces Apoptosis In Human Multiple Myeloma Cells In Vitro. Blood. 116(21). 3066–3066. 1 indexed citations
18.
Feldman, Tatyana, Anthony R. Mato, Aisha Masood, et al.. (2010). Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).. Journal of Clinical Oncology. 28(15_suppl). 8067–8067. 2 indexed citations
19.
Patel, Mehul, Aisha Masood, Priya Patel, & Asher Chanan‐Khan. (2009). Targeting the Bcl-2. Current Opinion in Oncology. 21(6). 516–523. 54 indexed citations
20.
Masood, Aisha & Sabah Sallah. (2004). Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leukemia Research. 29(5). 493–501. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Schnetzke Breakdown of academic impact, for papers by Toshiki Terao Breakdown of academic impact, for papers by Roninson Ib Breakdown of academic impact, for papers by Simone Jüliger Breakdown of academic impact, for papers by B W Futscher Breakdown of academic impact, for papers by Christopher Parsons Breakdown of academic impact, for papers by Katja Conrath Breakdown of academic impact, for papers by Daniela De Martino Breakdown of academic impact, for papers by Steven Schutt Breakdown of academic impact, for papers by Brian Kwok
Rankless by CCL
2026